{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,2]],"date-time":"2026-08-02T23:44:49Z","timestamp":1785714289665,"version":"3.56.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,24]],"date-time":"2026-05-24T00:00:00Z","timestamp":1779580800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T00:00:00Z","timestamp":1785715200000},"content-version":"vor","delay-in-days":71,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100007614","name":"Al Jouf University","doi-asserted-by":"publisher","award":["DGSSR-2024-01-01171"],"award-info":[{"award-number":["DGSSR-2024-01-01171"]}],"id":[{"id":"10.13039\/501100007614","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-54381-8","type":"journal-article","created":{"date-parts":[[2026,5,24]],"date-time":"2026-05-24T12:02:32Z","timestamp":1779624152000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["NMR-based metabolomics analysis in breast cancer patients from Saudi Arabia: a pilot study"],"prefix":"10.1038","volume":"16","author":[{"given":"Muhammad Ikram","family":"Ullah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shazia","family":"Rashid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aisha","family":"Tahir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayman Ali Mohammed","family":"Alameen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aisha","family":"Farhana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tarig Mohamed Fadl","family":"Elmula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziad H.","family":"Al-Oanzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,24]]},"reference":[{"key":"54381_CR1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21590","volume":"70","author":"RL Siegel","year":"2020","unstructured":"Siegel, R. L., Miller, K. D. & Jemal, A. Cancer statistics, 2020. CA. Cancer J. Clin. 70, 7\u201330. https:\/\/doi.org\/10.3322\/caac.21590 (2020).","journal-title":"CA. Cancer J. Clin."},{"key":"54381_CR2","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1007\/s00404-015-3859-y","volume":"293","author":"P Kumar","year":"2016","unstructured":"Kumar, P. & Aggarwal, R. An overview of triple-negative breast cancer. Arch. Gynecol. Obstet. 293, 247\u2013269. https:\/\/doi.org\/10.1007\/s00404-015-3859-y (2016).","journal-title":"Arch. Gynecol. Obstet."},{"key":"54381_CR3","doi-asserted-by":"publisher","DOI":"10.1186\/s13058-020-01296-5","volume":"22","author":"L Yin","year":"2020","unstructured":"Yin, L., Duan, J. J., Bian, X. W. & Yu, S. C. Triple-negative breast cancer molecular subtyping and treatment progress. Breast Cancer Res. 22, 61. https:\/\/doi.org\/10.1186\/s13058-020-01296-5 (2020).","journal-title":"Breast Cancer Res."},{"key":"54381_CR4","doi-asserted-by":"publisher","first-page":"2147","DOI":"10.1056\/NEJMoa1612645","volume":"376","author":"N Masuda","year":"2017","unstructured":"Masuda, N. et al. Adjuvant Capecitabine for breast cancer after preoperative chemotherapy. N. Engl. J. Med. 376, 2147\u20132159. https:\/\/doi.org\/10.1056\/NEJMoa1612645 (2017).","journal-title":"N. Engl. J. Med."},{"key":"54381_CR5","doi-asserted-by":"publisher","DOI":"10.3390\/ijms252313190","author":"DK Vo","year":"2024","unstructured":"Vo, D. K. & Trinh, K. T. L. Emerging biomarkers in metabolomics: Advancements in precision health and disease diagnosis. Int. J. Mol. Sci. https:\/\/doi.org\/10.3390\/ijms252313190 (2024).","journal-title":"Int. J. Mol. Sci."},{"key":"54381_CR6","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0169330","volume":"12","author":"A Singh","year":"2017","unstructured":"Singh, A. et al. 1H NMR metabolomics reveals association of high expression of inositol 1, 4, 5 trisphosphate receptor and metabolites in breast cancer patients. PLoS. One 12, e0169330. https:\/\/doi.org\/10.1371\/journal.pone.0169330 (2017).","journal-title":"PLoS. One"},{"key":"54381_CR7","doi-asserted-by":"publisher","DOI":"10.3390\/metabo15070428","author":"R Perestrelo","year":"2025","unstructured":"Perestrelo, R. & Lu\u00eds, C. Metabolomics in breast cancer: From biomarker discovery to personalized medicine. Metabolites https:\/\/doi.org\/10.3390\/metabo15070428 (2025).","journal-title":"Metabolites"},{"key":"54381_CR8","doi-asserted-by":"publisher","DOI":"10.3390\/metabo9050102","author":"C Silva","year":"2019","unstructured":"Silva, C., Perestrelo, R., Silva, P., Tom\u00e1s, H. & C\u00e2mara, J. S. Breast cancer metabolomics: From analytical platforms to multivariate data analysis. A review. Metabolites https:\/\/doi.org\/10.3390\/metabo9050102 (2019).","journal-title":"Metabolites"},{"key":"54381_CR9","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0274128","volume":"17","author":"S Vicente-Mu\u00f1oz","year":"2022","unstructured":"Vicente-Mu\u00f1oz, S., Hunt, B. G., Lange, T. E., Wells, S. I. & Waltz, S. E. NMR-based metabolomic analysis identifies RON-DEK-\u03b2-catenin dependent metabolic pathways and a gene signature that stratifies breast cancer patient survival. PLoS. One 17, e0274128. https:\/\/doi.org\/10.1371\/journal.pone.0274128 (2022).","journal-title":"PLoS. One"},{"key":"54381_CR10","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1038\/nprot.2011.335","volume":"6","author":"WB Dunn","year":"2011","unstructured":"Dunn, W. B. et al. Procedures for large-scale metabolic profiling of serum and plasma using gas chromatography and liquid chromatography coupled to mass spectrometry. Nat. Protoc. 6, 1060\u20131083. https:\/\/doi.org\/10.1038\/nprot.2011.335 (2011).","journal-title":"Nat. Protoc."},{"key":"54381_CR11","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1007\/978-1-4939-7493-1_9","volume-title":"Methods Mol Biol","author":"LR Euceda","year":"2018","unstructured":"Euceda, L. R., Haukaas, T. H., Bathen, T. F. & Giske\u00f8deg\u00e5rd, G. F. Prediction of Clinical Endpoints in Breast Cancer Using NMR Metabolic Profiles. In Methods Mol Biol Vol. 1711 167\u2013189 (2018). https:\/\/doi.org\/10.1007\/978-1-4939-7493-1_9."},{"key":"54381_CR12","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2021.708052","volume":"8","author":"X He","year":"2021","unstructured":"He, X. et al. NMR-based metabolomics analysis predicts response to neoadjuvant chemotherapy for triple-negative breast cancer. Front. Mol. Biosci. 8, 708052. https:\/\/doi.org\/10.3389\/fmolb.2021.708052 (2021).","journal-title":"Front. Mol. Biosci."},{"key":"54381_CR13","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22094687","author":"A Vignoli","year":"2021","unstructured":"Vignoli, A. et al. Precision oncology via NMR-based metabolomics: A review on breast cancer. Int. J. Mol. Sci. https:\/\/doi.org\/10.3390\/ijms22094687 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"54381_CR14","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1007\/978-1-4939-9690-2_12","volume":"2037","author":"U Sharma","year":"2019","unstructured":"Sharma, U. & Jagannathan, N. R. Breast cancer metabolomics using NMR. Methods Mol. Biol. 2037, 195\u2013213. https:\/\/doi.org\/10.1007\/978-1-4939-9690-2_12 (2019).","journal-title":"Methods Mol. Biol."},{"key":"54381_CR15","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-73097-1","volume":"14","author":"W Wojtowicz","year":"2024","unstructured":"Wojtowicz, W. et al. Serum metabolite and metal ions profiles for breast cancer screening. Sci. Rep. 14, 24559. https:\/\/doi.org\/10.1038\/s41598-024-73097-1 (2024).","journal-title":"Sci. Rep."},{"key":"54381_CR16","doi-asserted-by":"publisher","DOI":"10.3390\/metabo11110758","author":"MM Al-Ansari","year":"2021","unstructured":"Al-Ansari, M. M., AlMalki, R. H., Dahabiyeh, L. A. & Abdel Rahman, A. M. Metabolomics-microbiome crosstalk in the breast cancer microenvironment. Metabolites https:\/\/doi.org\/10.3390\/metabo11110758 (2021).","journal-title":"Metabolites"},{"key":"54381_CR17","doi-asserted-by":"publisher","first-page":"1734","DOI":"10.1038\/s41416-021-01304-1","volume":"124","author":"E Jobard","year":"2021","unstructured":"Jobard, E. et al. Investigation of circulating metabolites associated with breast cancer risk by untargeted metabolomics: A case-control study nested within the French E3N cohort. Br. J. Cancer 124, 1734\u20131743. https:\/\/doi.org\/10.1038\/s41416-021-01304-1 (2021).","journal-title":"Br. J. Cancer"},{"key":"54381_CR18","first-page":"353","volume":"10","author":"MH Al-Qahtani","year":"2016","unstructured":"Al-Qahtani, M. H. Dietary habits of Saudi medical students at University of Dammam. Int J Health Sci (Qassim) 10, 353\u2013362 (2016).","journal-title":"Int J Health Sci (Qassim)"},{"key":"54381_CR19","doi-asserted-by":"publisher","first-page":"679","DOI":"10.3934\/publichealth.2020053","volume":"7","author":"WS Alqahtani","year":"2020","unstructured":"Alqahtani, W. S. et al. Epidemiology of cancer in Saudi Arabia thru 2010\u20132019: A systematic review with constrained meta-analysis. AIMS Public Health 7, 679\u2013696. https:\/\/doi.org\/10.3934\/publichealth.2020053 (2020).","journal-title":"AIMS Public Health"},{"key":"54381_CR20","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2022.863029","volume":"9","author":"FS Azzeh","year":"2022","unstructured":"Azzeh, F. S. et al. Consumption of food components of the Mediterranean Diet decreases the risk of breast cancer in the Makkah Region, Saudi Arabia: A case-control study. Front. Nutr. 9, 863029. https:\/\/doi.org\/10.3389\/fnut.2022.863029 (2022).","journal-title":"Front. Nutr."},{"key":"54381_CR21","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1080\/26895293.2022.2082540","volume":"15","author":"G Ahmed","year":"2022","unstructured":"Ahmed, G. Histopathologic metrics of breast tumors in Northern Saudi Arabia. All Life. 15, 649\u2013655. https:\/\/doi.org\/10.1080\/26895293.2022.2082540 (2022).","journal-title":"All Life"},{"key":"54381_CR22","doi-asserted-by":"publisher","first-page":"8128","DOI":"10.1021\/acsomega.2c00083","volume":"7","author":"HM Morad","year":"2022","unstructured":"Morad, H. M., Abou-Elzahab, M. M., Aref, S. & El-Sokkary, A. M. A. Diagnostic value of (1)H NMR-based metabolomics in acute lymphoblastic leukemia, acute myeloid leukemia, and breast cancer. ACS Omega 7, 8128\u20138140. https:\/\/doi.org\/10.1021\/acsomega.2c00083 (2022).","journal-title":"ACS Omega"},{"key":"54381_CR23","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1007\/s11306-023-01972-5","volume":"19","author":"A Shekher","year":"2023","unstructured":"Shekher, A. et al. Association of altered metabolic profiles and long non-coding RNAs expression with disease severity in breast cancer patients: analysis by (1)H NMR spectroscopy and RT-q-PCR. Metabolomics 19, 8. https:\/\/doi.org\/10.1007\/s11306-023-01972-5 (2023).","journal-title":"Metabolomics"},{"key":"54381_CR24","unstructured":"Yanshole, V. V. et al. in Preprints (Preprints, 2024)."},{"key":"54381_CR25","doi-asserted-by":"publisher","DOI":"10.1007\/s11306-020-01666-2","volume":"16","author":"H Bi","year":"2020","unstructured":"Bi, H. et al. The key points in the pre-analytical procedures of blood and urine samples in metabolomics studies. Metabolomics 16, 68. https:\/\/doi.org\/10.1007\/s11306-020-01666-2 (2020).","journal-title":"Metabolomics"},{"key":"54381_CR26","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1373\/clinchem.2012.199257","volume":"59","author":"P Yin","year":"2013","unstructured":"Yin, P. et al. Preanalytical aspects and sample quality assessment in metabolomics studies of human blood. Clin. Chem. 59, 833\u2013845. https:\/\/doi.org\/10.1373\/clinchem.2012.199257 (2013).","journal-title":"Clin. Chem."},{"key":"54381_CR27","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-99845-5","volume":"15","author":"S Hussain","year":"2025","unstructured":"Hussain, S. et al. Role of metabolomic changes in diagnosis and assessment of treatment response in acute myeloid leukemia. Sci. Rep. 15, 28576. https:\/\/doi.org\/10.1038\/s41598-025-99845-5 (2025).","journal-title":"Sci. Rep."},{"key":"54381_CR28","doi-asserted-by":"publisher","first-page":"e765","DOI":"10.1016\/j.clbc.2025.05.005","volume":"25","author":"CJ Vellan","year":"2025","unstructured":"Vellan, C. J., Natesan, V. & Jayapalan, J. J. Metabolomics biomarkers for breast cancer: An updated perspective. Clin. Breast Cancer 25, e765\u2013e778. https:\/\/doi.org\/10.1016\/j.clbc.2025.05.005 (2025).","journal-title":"Clin. Breast Cancer"},{"key":"54381_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/s41416-025-03159-2","author":"T Wang","year":"2025","unstructured":"Wang, T. et al. Prospective study of circulating metabolomic profiles and breast cancer incidence among predominantly premenopausal women. Br. J. Cancer https:\/\/doi.org\/10.1038\/s41416-025-03159-2 (2025).","journal-title":"Br. J. Cancer"},{"key":"54381_CR30","doi-asserted-by":"publisher","DOI":"10.3390\/cells14010005","author":"R Kaur","year":"2024","unstructured":"Kaur, R. et al. Metabolomics-driven biomarker discovery for breast cancer prognosis and diagnosis. Cells https:\/\/doi.org\/10.3390\/cells14010005 (2024).","journal-title":"Cells"},{"key":"54381_CR31","doi-asserted-by":"publisher","DOI":"10.1007\/s11306-019-1610-6","volume":"15","author":"N Harada-Shoji","year":"2019","unstructured":"Harada-Shoji, N. et al. A metabolic profile of routine needle biopsies identified tumor type specific metabolic signatures for breast cancer stratification: A pilot study. Metabolomics 15, 147. https:\/\/doi.org\/10.1007\/s11306-019-1610-6 (2019).","journal-title":"Metabolomics"},{"key":"54381_CR32","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2024.1377373","author":"K Mrowiec","year":"2024","unstructured":"Mrowiec, K. et al. Profiling of serum metabolome of breast cancer: Multi-cancer features discriminate between healthy women and patients with breast cancer. Front. Oncol. https:\/\/doi.org\/10.3389\/fonc.2024.1377373 (2024).","journal-title":"Front. Oncol."},{"key":"54381_CR33","doi-asserted-by":"publisher","first-page":"120","DOI":"10.15537\/smj.2026.47.1.20250578","volume":"47","author":"JS AlRahimi","year":"2026","unstructured":"AlRahimi, J. S. et al. National Heart Center\/Saudi Heart Association 2025 guidelines for cardiovascular diseases prevention and risk assessment. Saudi Med. J. 47, 120\u2013177. https:\/\/doi.org\/10.15537\/smj.2026.47.1.20250578 (2026).","journal-title":"Saudi Med. J."},{"key":"54381_CR34","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.cmet.2007.10.002","volume":"7","author":"RJ DeBerardinis","year":"2008","unstructured":"DeBerardinis, R. J., Lum, J. J., Hatzivassiliou, G. & Thompson, C. B. The biology of cancer: metabolic reprogramming fuels cell growth and proliferation. Cell. Metab. 7, 11\u201320. https:\/\/doi.org\/10.1016\/j.cmet.2007.10.002 (2008).","journal-title":"Cell. Metab."},{"key":"54381_CR35","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.tibs.2010.05.003","volume":"35","author":"DR Wise","year":"2010","unstructured":"Wise, D. R. & Thompson, C. B. Glutamine addiction: A new therapeutic target in cancer. Trends Biochem. Sci. 35, 427\u2013433. https:\/\/doi.org\/10.1016\/j.tibs.2010.05.003 (2010).","journal-title":"Trends Biochem. Sci."},{"key":"54381_CR36","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1038\/nrc.2016.87","volume":"16","author":"ZT Schug","year":"2016","unstructured":"Schug, Z. T., Vande Voorde, J. & Gottlieb, E. The metabolic fate of acetate in cancer. Nat. Rev. Cancer 16, 708\u2013717. https:\/\/doi.org\/10.1038\/nrc.2016.87 (2016).","journal-title":"Nat. Rev. Cancer"},{"key":"54381_CR37","doi-asserted-by":"publisher","DOI":"10.1126\/science.aaw5473","author":"B Faubert","year":"2020","unstructured":"Faubert, B., Solmonson, A. & DeBerardinis, R. J. Metabolic reprogramming and cancer progression. Science https:\/\/doi.org\/10.1126\/science.aaw5473 (2020).","journal-title":"Science"},{"key":"54381_CR38","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1097\/mco.0000000000000430","volume":"21","author":"EA Ananieva","year":"2018","unstructured":"Ananieva, E. A. & Wilkinson, A. C. Branched-chain amino acid metabolism in cancer. Curr. Opin. Clin. Nutr. Metab. Care 21, 64\u201370. https:\/\/doi.org\/10.1097\/mco.0000000000000430 (2018).","journal-title":"Curr. Opin. Clin. Nutr. Metab. Care"},{"key":"54381_CR39","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1007\/s11306-013-0598-6","volume":"10","author":"E Saccenti","year":"2014","unstructured":"Saccenti, E., Hoefsloot, H. C. J., Smilde, A. K., Westerhuis, J. A. & Hendriks, M. M. W. B. Reflections on univariate and multivariate analysis of metabolomics data. Metabolomics 10, 361\u2013374. https:\/\/doi.org\/10.1007\/s11306-013-0598-6 (2014).","journal-title":"Metabolomics"},{"key":"54381_CR40","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1007\/s11306-012-0482-9","volume":"9","author":"J Xia","year":"2013","unstructured":"Xia, J., Broadhurst, D. I., Wilson, M. & Wishart, D. S. Translational biomarker discovery in clinical metabolomics: An introductory tutorial. Metabolomics 9, 280\u2013299. https:\/\/doi.org\/10.1007\/s11306-012-0482-9 (2013).","journal-title":"Metabolomics"},{"key":"54381_CR41","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1093\/annonc\/mdq606","volume":"22","author":"C Oakman","year":"2011","unstructured":"Oakman, C. et al. Identification of a serum-detectable metabolomic fingerprint potentially correlated with the presence of micrometastatic disease in early breast cancer patients at varying risks of disease relapse by traditional prognostic methods. Ann. Oncol. 22, 1295\u20131301. https:\/\/doi.org\/10.1093\/annonc\/mdq606 (2011).","journal-title":"Ann. Oncol."},{"key":"54381_CR42","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1016\/s0895-4356(03)00207-5","volume":"56","author":"SE Bleeker","year":"2003","unstructured":"Bleeker, S. E. et al. External validation is necessary in prediction research: a clinical example. J. Clin. Epidemiol. 56, 826\u2013832. https:\/\/doi.org\/10.1016\/s0895-4356(03)00207-5 (2003).","journal-title":"J. Clin. Epidemiol."},{"key":"54381_CR43","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1158\/1535-7163.Mct-13-0870","volume":"13","author":"MI Gross","year":"2014","unstructured":"Gross, M. I. et al. Antitumor activity of the glutaminase inhibitor CB-839 in triple-negative breast cancer. Mol. Cancer Ther. 13, 890\u2013901. https:\/\/doi.org\/10.1158\/1535-7163.Mct-13-0870 (2014).","journal-title":"Mol. Cancer Ther."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-54381-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-54381-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-54381-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,2]],"date-time":"2026-08-02T22:53:33Z","timestamp":1785711213000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-54381-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,24]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["54381"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-54381-8","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,24]]},"assertion":[{"value":"24 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"23750"}}